LG Life Sciences’ single dose treatment of osteoarthritis Synovan Inj obtained the European CE certification
On August 20, LG Life Sciences announced that the first Korean developed single dose treatment of osteoarthritis drug Synovan Inj obtained the European CE certification.
LG Life Sciences received this certificatio based on the clinical results and a lot of safety evidence, and it became possible...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
